Clinical Trial Update: Sevoflurane in COVID-19 ARDS (SevCov) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating sevoflurane for COVID-19 ARDS has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019
• Respiratory Distress Syndrome

Drugs mentioned

• Sevoflurane (Sevoflurane)

Snippet

Sponsor: University of Zurich | Conditions: ARDS, Human, Coronavirus | Phase 3 | Status: COMPLETED